SLC2A1 and melanoma: Oleuropein was demonstrated to be able to prevent the development of melanoma, colorectal, breast, and chronic myoid leukemia by suppressing the expression of GLUT1, MCT1 and PKM2 in the glycolysis pathway (Ruzzolini et al., 2020).